Indivior Inc.   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Richmond VA United States (2014)

Organization Overview

First Clinical Trial
2014
NCT00279565
First Marketed Drug
2014
buprenorphine
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

INDIVIOR | Indivior Inc. | INDIVIOR INC | Indivior, PLC.